May 28, 2016 8:05 AM ET

Pharmaceuticals

Company Overview of Luitpold Pharmaceuticals, Inc.

Key Executives for Luitpold Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Mary Jane Helenek No RelationshipsChief Executive Officer and President--
Jean M. Bellin 8 RelationshipsVice President 64

Luitpold Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
There is no Board Members data available.

Luitpold Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
389.7K
Bonus
550.0K
Total Short Term Compensation
582.6K
Total Value of Options
14.9M
Compensation as of Fiscal Year
Luitpold Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Glaxosmithkline plc Appoints Vivienne Cox to the Board as Non-Executive Director with Effect from 1 July 2016
May 27, 2016 1:56 PM ET
Orexigen Therapeutics Announces Resignation of Eckard Weber from the Board
May 27, 2016 1:00 PM ET
Recce Limited Appoints Bernadette Murdoch as Independent Non-Executive Director
May 27, 2016 4:21 AM ET
Abattis Bioceuticals Corp. Appoints Maryam Amin Shanjani to the Board of Directors
May 26, 2016 3:55 PM ET
Photocure ASA Announces Resignation of Kathleen Deardorff as Chief Operating Officer
May 26, 2016 2:46 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Luitpold Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.